Unfavorable transcriptome profiles and social disadvantage in hematopoietic cell transplantation: a CIBMTR analysis
Mallory Taylor(Center for Cancer and Blood Disorders), Jennifer M. Knight(Medical College of Wisconsin), Michelle A. Lee(Boston Children's Hospital), Steve W. Cole(APLA Health), Joelle Strom(Medical College of Wisconsin), K. Scott Baker(Malaria Consortium), Bronwen E. Shaw(Royal Marsden NHS Foundation Trust), Lena E. Winestone(University of California, San Francisco), Neel S. Bhatt(The Ohio State University Wexner Medical Center), Betty K. Hamilton(Cleveland Clinic), David Buchbinder(Children's Hospital of Orange County), Taiga Nishihori(Moffitt Cancer Center), Sherif M. Badawy(Northwestern University), Ruta Brazauskas(Medical College of Wisconsin), Akshay Sharma(St. Jude Children's Research Hospital), Samantha Mayo(University of Toronto), Jaime M. Preussler(National Marrow Donor Program), Kareem Jamani(Fred Hutch Cancer Center), Rachel Phelan(Children's Hospital of Wisconsin), Hélène Schoemans(KU Leuven)
Cited by 12
Related Papers
Current Use of and Trends in Hematopoietic Cell Transplantation in the United States
|Transplantation and Cellular Therapy|2020|718
EBMT−NIH−CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment
|Bone Marrow Transplantation|2018|479
Human Social Genomics
|PLoS Genetics|2014|411